These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 402662)

  • 1. Pharmacological and biochemical studies with three metabolites of nomifensine.
    Kruse H; Hoffmann I; Gerhards HJ; Leven M; Schacht U
    Psychopharmacology (Berl); 1977 Jan; 51(2):117-23. PubMed ID: 402662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nomifensine and its derivatives as possible tools for studying amine uptake.
    Tuomisto J
    Eur J Pharmacol; 1977 Mar; 42(2):101-6. PubMed ID: 844493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology in vivo of the phenylindan derivative, Lu 19-005, a new potent inhibitor of dopamine, noradrenaline and 5-hydroxytryptamine uptake in rat brain.
    Arnt J; Christensen AV; Hyttel J
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Apr; 329(2):101-7. PubMed ID: 2409454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of nomifensine (HOE 984), a new antidepressant, on uptake of noradrenaline and serotonin and on release of noradrenaline in rat brain synaptosomes.
    Schacht U; Heptner W
    Biochem Pharmacol; 1974 Dec; 23(24):3413-22. PubMed ID: 4441422
    [No Abstract]   [Full Text] [Related]  

  • 5. Methylphenidate-like effects of the new antidepressant drug nomifensine (HOE 984).
    Braestrup C; Scheel-Krüger J
    Eur J Pharmacol; 1976 Aug; 38(2):305-12. PubMed ID: 986308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The blockade of serotonin uptake into synaptosomes:relationship to an interaction with monoamine oxidase inhibitors.
    Sinclair JG; Lo GF
    Can J Physiol Pharmacol; 1977 Apr; 55(2):180-7. PubMed ID: 17455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of nomifensine on the depletion of brain serotonin and catecholamines induced respectively by fenfluramine and 6-hydroxydopamine in rats.
    Samanin R; Bernasconi S; Garattini S
    Eur J Pharmacol; 1975 Dec; 34(2):377-80. PubMed ID: 1234558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of in vitro amine uptake into rat brain synaptosomes after in vivo administration of antidepressants.
    Manias B; Taylor DA
    Eur J Pharmacol; 1983 Nov; 95(3-4):305-9. PubMed ID: 6653676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Du 24565, a quipazine derivative, a potent selective serotonin uptake inhibitor.
    Vaatstra WJ; Deiman-Van Aalst WM; Eigeman L
    Eur J Pharmacol; 1981 Mar; 70(2):195-202. PubMed ID: 6973481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uptake inhibition of biogenic amines by newer antidepressant drugs: relevance to the dopamine hypothesis of depression.
    Randrup A; Braestrup C
    Psychopharmacology (Berl); 1977 Aug; 53(3):309-14. PubMed ID: 408861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. McN-5652: a highly potent inhibitor of serotonin uptake.
    Shank RP; Vaught JL; Pelley KA; Setler PE; McComsey DF; Maryanoff BE
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1032-8. PubMed ID: 2905001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressive effects of the stereoisomer cis-dosulepin hydrochloride.
    Nakagawa T; Ukai K; Kubo S
    Arzneimittelforschung; 1993 Jan; 43(1):11-5. PubMed ID: 8447840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological profile of the novel antidepressant 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno-[2,3-d]pyrimidine monohydrate hydrochloride.
    Eguchi J; Inomata Y; Yuasa T; Egawa M; Saito K
    Arzneimittelforschung; 1997 Dec; 47(12):1337-47. PubMed ID: 9450161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diclofensine (Ro 8-4650)--a potent inhibitor of monoamine uptake: biochemical and behavioural effects in comparison with nomifensine.
    Keller HH; Schaffner R; Carruba MO; Burkard WP; Pieri M; Bonetti EP; Scherschlicht R; Da Prada M; Haefely WE
    Adv Biochem Psychopharmacol; 1982; 31():249-63. PubMed ID: 6979165
    [No Abstract]   [Full Text] [Related]  

  • 15. Biochemical effects of the antidepressant paroxetine, a specific 5-hydroxytryptamine uptake inhibitor.
    Thomas DR; Nelson DR; Johnson AM
    Psychopharmacology (Berl); 1987; 93(2):193-200. PubMed ID: 2962217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyrroloisoquinoline antidepressants. 2. In-depth exploration of structure-activity relationships.
    Maryanoff BE; McComsey DF; Gardocki JF; Shank RP; Costanzo MJ; Nortey SO; Schneider CR; Setler PE
    J Med Chem; 1987 Aug; 30(8):1433-54. PubMed ID: 3039136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Differences in the mechanisms of the stimulant and antidepressive effects of nomifensine].
    Chermat R; Poncelet M; Simon P
    J Pharmacol; 1985; 16(1):7-13. PubMed ID: 2860270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on brain metabolism of biogenic amines.
    Schacht U; Leven M; Bäcker G
    Br J Clin Pharmacol; 1977; 4Suppl 2(Suppl 2):77S-87S. PubMed ID: 199222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical evaluation of McN-5707 as a potential antidepressant.
    Shank RP; Gardocki JF; Schneider CR; Vaught JL; Setler PE; Maryanoff BE; McComsey DF
    J Pharmacol Exp Ther; 1987 Jul; 242(1):74-84. PubMed ID: 3039115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute effects of nomifensine on in vivo uptake and metabolism of dopamine, noradrenaline and serotonin in the rat brain.
    Broch OJ
    Pharmacol Toxicol; 1987 Jan; 60(1):70-4. PubMed ID: 3562394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.